Home
Conditions
Multiple Myeloma

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

1,662 public trials 323 recruiting studies

Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Completed

First Line Treatment Trial in Multiple Myeloma, Finnish Myeloma Group- Multiple Myeloma 02

NCT01790737

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Kuopio University Hospital Kuopio, Northern Savonia, Finland

Tampere University Hospital Tampere, Pirkanmaa, Finland

Kanta-Häme Central Hospital Hämeenlinna, Finland

Helsinki University Hospital Helsinki, Finland

View Trial Details

Completed

Effect of Eltrombopag Plus G-CSF on Human CD34+ Cell Mobilization in Multiple Myeloma Patients Undergoing ASCT

NCT01286675

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

A Study of the First-line Treatment of Patients With Newly Diagnosed Transplant-ineligible Multiple Myeloma in Spain

NCT03602755

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: H. Santiago (CHUS) Santiago de Compostela, A Coruña, Spain

H. Txagorritxu Vitoria-Gasteiz, Alava, Spain

H. Son Espases Palma, Balearic Islands, Spain

ICO Duran i Reynals L'Hospitalet de Llobregat, Barcelona, Spain

View all 20 locations

View Trial Details

Completed

Standard Care Alone or With Acupuncture for CIPN in Breast Cancer and Multiple Myeloma

NCT02275403

Conditions: Blood Protein Disorders, Breast Cancer, Breast Diseases, +24 more
Locations: The Christie NHS Foundation Trust Manchester, United Kingdom

The Royal Oldham Hospital Oldham, United Kingdom

View Trial Details

Completed

Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing IN Gammopathy Patients

NCT02566265

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +25 more
Locations: Yale University New Haven, Connecticut, United States

View Trial Details

Completed

Reduced Intensity Double Umbilical Cord Blood Transplantation

NCT01408563

Conditions: Acute Myelogenous Leukemia, Anemia, Anemia, Aplastic, +34 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation

NCT01634217

Conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Blood Protein Disorders, +38 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Study of the Combination of Panobinostat & Carfilzomib in Patients With Relapsed &/or Refractory Multiple Myeloma

NCT01549431

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States

Emory University Winship Cancer Institute Atlanta, Georgia, United States

University of Chicago Chicago, Illinois, United States

View Trial Details

Completed

Allogeneic GM-CSF Vaccine and Lenalidomide in Treating Myeloma Patients With Near Complete Remission

NCT01349569

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Everolimus and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Hematologic Cancer

NCT02240719

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +35 more
Locations: University of California Davis Sacramento, California, United States

View Trial Details

Multiple Myeloma

Multiple Myeloma trial results

Related conditions